Publicaciones (92) Publicaciones de Javier García Castro

2023

  1. Switchable CAR T cell strategy against osteosarcoma

    Cancer Immunology, Immunotherapy, Vol. 72, Núm. 8, pp. 2623-2633

  2. Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing

    CANCER RESEARCH COMMUNICATIONS, Vol. 3, Núm. 3, pp. 347-360

2022

  1. Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide Treatment

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients

    Veterinary Sciences, Vol. 9, Núm. 7

  3. Systemic cellular viroimmunotherapy for canine high-grade gliomas

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 12, pp. e005669

2021

  1. AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses

    Cancer Gene Therapy, Vol. 28, Núm. 1-2, pp. 64-73

  2. Cancer stem cells and clonal evolution in bone sarcomas

    Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside (Elsevier), pp. 371-391

  3. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

  4. Humoral responses to SARS-CoV-2 by healthy and sick dogs during the COVID-19 pandemic in Spain

    Veterinary Research, Vol. 52, Núm. 1

  5. Rgb-marking to identify patterns of selection and neutral evolution in human osteosarcoma models

    Cancers, Vol. 13, Núm. 9

  6. Systemic treatment of immune-mediated keratoconjunctivitis sicca with allogeneic stem cells improves the schirmer tear test score in a canine spontaneous model of disease

    Journal of Clinical Medicine, Vol. 10, Núm. 24

  7. The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation

    Cell Adhesion and Migration, Vol. 15, Núm. 1, pp. 58-73

2020

  1. Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy

    Molecular Therapy - Oncolytics, Vol. 18, pp. 525-534

  2. Cellular virotherapy increases tumor-infiltrating lymphocytes (Til) and decreases their pd-1+ subsets in mouse immunocompetent models

    Cancers, Vol. 12, Núm. 7, pp. 1-17

  3. First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors

    Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042

  4. Immunotherapy with CAR-T cells in paediatric haematology-oncology

    Anales de Pediatria, Vol. 93, Núm. 1, pp. 59.e1-59.e10

  5. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

  6. Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications

    Cancers, Vol. 12, Núm. 4

2019

  1. Corrigendum: H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells

    Genome research

  2. Enhanced antitumor efficacy of oncolytic adenovirus–loaded menstrual blood–derived mesenchymal stem cells in combination with peripheral blood mononuclear cells

    Molecular Cancer Therapeutics, Vol. 18, Núm. 1, pp. 127-138